Boston Scientific Recalls Stents
Shares in Boston Scientific (BSX Quote) fell Friday as the company said it was recalling about 200 of its Taxus drug-coated stents.
The Natick, Mass.-based company said it made the move because of characteristics in the delivery catheters that have the potential to impede balloon deflation during a coronary angioplasty procedure ... which can result in significant patient complications, including coronary artery bypass graft surgery and death."
The company said it had informed the Food and Drug Administration, which has received reports of one death and 16 serious injuries associated with balloon deflation. A stent is a tiny device inserted into arteries to improve blood flow and reduce the risk of heart disease and heart attack. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,344.84 | 1,095.63 | 2,144.60 | 32.01 |
Oil *
78.55
|
|
UP
34.92
|
UP
4.14
|
UP
6.16
|
DOWN
0.30
|
10 Yr
3.20%
SPDR Gold
115.65
|
|
+0.34%
|
+0.38%
|
+0.29%
|
-0.93%
|
Data delayed 20 minutes |


Connect with TheStreet